DLL4, Fc Fusion, Avi-Tag Recombinant

Products from BPS Bioscience require a minimum order value above 400€

Encompassing Amino Acids: 27-529

Application: Useful to study  the binding of DLL4 in ELISA and in cellular assays.

Background: DLL4, or delta-like canonical Notch ligand 4, is part of the Notch signaling pathway and it is involved in normal tissue development and homeostasis. It is an agonist ligand and can bind to the four Notch receptors. It is expressed in the vascular system and plays a crucial role in angiogenesis. Loss of function of DLL4 results in VEGF upregulation, and the formation of immature vessels without a lumen. It has been shown that DLL4 inhibition can actually result in tumor regression by its role on VEGF upregulation. DLL4 is found in several tumor types, and it is found in tumor stem cells. Inhibition of DLL4 can thus contribute to cancer therapy via its several mechanisms of action.

Description: Recombinant human DLL4 (delta-like canonical Notch ligand 4), encompassing amino acids 27-529. This construct contains the Fc region of human IgG1  on the C-terminus, followed by an Avi-Tag™. This protein was affinity purified.

Format: Aqueous buffer solution.

Formulation: 8 mM phosphate, pH 7.4, 110 mM NaCl, 2.2 mM KCl, and 20% glycerol

Genbank: NM_019074.4

Host Cell Line: HEK293

Purity: ≥90%

Storage Stability: At least 6 months at -80°C.

Tags: C-terminal Avi-Tag™

Uniprot: Q9NR61

Warnings: Avoid freeze/thaw cycles

Biosafety Level: Not applicable (BSL-1)

• Artikelnummer: BPS101903-2
• Hersteller: BPS Bioscience
• Hersteller Artikelnummer: 101903-2
• Verpackungseinheit: 50 µg
• Mengeneinheit: STK
• Methode: ELISA
• Wirt: Human